Aurinia Pharmaceuticals Inc (AUPH) is down Thursday morning, with the stock decreasing -6.00% in pre-market trading to 7.99.
AUPH's short-term technical score of 77 indicates that the stock has traded more bullishly over the last month than 77% of stocks on the market. In the Biotechnology industry, which ranks 88 out of 146 industries, AUPH ranks higher than 81% of stocks.
Aurinia Pharmaceuticals Inc has fallen 25.37% over the past month, closing at $12.27 on July 7. During this period of time, the stock fell as low as $8.14 and as high as $12.60. AUPH has an average analyst recommendation of Strong Buy. The company has an average price target of $23.31.
AUPH has an Overall Score of 59. Find out what this means to you and get the rest of the rankings on AUPH!
Aurinia Pharmaceuticals Inc has a Long-Term Technical rank of 13. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 87% of the market scoring higher. In the Biotechnology industry which is number 101 by this metric, AUPH ranks better than 101% of stocks.
